LASERS, MICROBIOLOGY AND DENTAL MATERIALS IN CLINICAL DENTAL PRACTICE
Professor Laurence Walsh AO
Emeritus Professor, School of Dentistry, University of Queensland &
Adjunct Professor, Griffith University, Queensland &
Chief Dental Officer, Dentroid
RESEARCHER PROFILE
Filmed in Brisbane, Queensland, Australia | December 2024
Prof Walsh is a well known senior dental academic and dental board registered specialist in special needs dentistry. He completed his basic dental training and his PhD at the University of Queensland and then his post doctoral education at the University of Pennsylvania School of Medicine, followed by executive education at Stanford University and Harvard University. In addition to his multiple dental and educational qualifications, Prof Walsh is a member of the Australian Institute of Safety and Health, and an associate member of the Australian Institute of Physics. He has served for over 25 years as a laser safety officer. Prof Walsh was a member of the UQ Centre for Laser Science for 11 years.
Prof Walsh has one major national awards for research and teaching excellence, and has been made a life member of the ANZ Academy of special needs dentistry, and the Australian Dental Association. In 2018, he was appointed as an officer of the order of Australia (AO) in recognition of his contributions to dental education and dental research.
Prof Walsh has served on the academic staff of the University of Queensland School of Dentistry for 40 years, including for 21 years as the research group leader in advanced technologies. Since retiring from UQ in 2020 and then being appointed as an emeritus professor, Prof Walsh has continued his involvement with specialist training and clinical research at UQ, and continued applied research in advanced technologies.
Prof Walsh was Australia’s first multi-wavelength laser user in 1988, and he has published over 100 articles and 3 textbooks on the topic of laser dentistry. He has a further 300 journal publications on other topics, and his published work has attracted over 20,000 citations in the literature. Based on citation impact, in October 2023 Prof Walsh was ranked in the top 5 Australian dental scientists of all time in the Stanford University listing of the world’s top 2% of scientists.
Prof Walsh has represented the Australian Dental Association on multiple committees of Standards Australia since 1992 (including laser safety). He has taught laser safety and clinical laser procedures around the world for over 30 years. Prof Walsh has been the president of the Australian Association for laser dentistry since 2018.
-
CASE STUDY Next Generation Condom Contraception
Eudaemon Technologies, an early-stage medtech company with a focus on sexual reproductive health, is developing a hydrogel condom to address the need for a better feeling, next generation condom, with the potential to improve user experience and address issues with traditional latex condoms.
“Over 1 million STI’s being diagnosed every day and up to 120 million unplanned pregnancies every year result in a $60 billion health burden across the globe”, says Co-Founder and Executive Director of Operations, Dr Simon Cook.
Formed in 2018, the company focuses on developing tough hydrogels as an alternative to address issues with odour, colour, and taste commonly associated with latex condoms. This technology can be loaded with small molecule drugs for flavours or anti-STI compounds, and was developed in response to a grant from the Bill and Melinda Gates Foundation to address unplanned pregnancies and STIs.
-
Biostatistics in Clinical Trials
As a biostatistician working in research and clinical settings, Kate Francis plays a vital role in ensuring all projects adhere to best practice guidelines and are transparently reported. She has served as the lead statistician for the analysis of clinical trials across a broad range of subject areas, including neonatal resuscitation, BCG for allergy and infection, convulsive status epilepticus and her work has been published in the top journals such as The New England Journal of Medicine, JAMA, and The Lancet. Most recently she was awarded the 2025 Excellence in Trial Statistics Award for her work on the PLUSS trial.
-
Novel forms of brain stimulation & psychedelic assisted psychotherapy
Professor Paul Fitzgerald is the Head of the School of Medicine and Psychology at the Australian National University. He is an academic psychiatrist with a MBBS degree, Masters of Psychological Medicine and research PhD. He has conducted an extensive range of experimental studies and clinical trials, focused on the development of novel treatment options for patients with mental health conditions such as depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease.
